Hyaluronic acid intra-articular injection and exercise therapy: Effects on pain and disability in subjects affected by lower limb joints osteoarthritis A systematic review by the Italian Society of Physical and Rehabilitation Medicine (SIMFER)

European Journal of Physical and Rehabilitation Medicine

Volumn 52, Issue 3, 2016, Pages 389-399

  Monticone, Marco ^a   Frizziero, Antonio ^b   Rovere, Giancarlo ^c   Vittadini, Filippo ^b   Uliano, Domenico ^d   La Bruna, Silvano ^e   Gatto, Renato ^f   Nava, Claudia ^a   Leggero, Vittorio ^a   Masiero, Stefano ^b  

^a IRCCS   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Novi Ligure   (Italy)

^d KINESIS Physical Lherapy and Rehabilitation Center   (Italy)

^e Rehabilitation Unit   (Italy)

^f Cardiology Unit   (Italy)

Author keywords

Hyaluronic acid; Intra articular injection; Osteoarthritis; Physical exercises; Physical therapy modality; Rehabilitation

Indexed keywords

HYALURONIC ACID;

AGED; ANKLE; COMPARATIVE STUDY; FEMALE; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; KINESIOTHERAPY; MALE; MIDDLE AGED; OSTEOARTHRITIS; OSTEOARTHRITIS, KNEE; PAIN; PATHOPHYSIOLOGY; QUALITY OF LIFE;

AGED; ANKLE; EXERCISE THERAPY; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; OSTEOARTHRITIS; OSTEOARTHRITIS, KNEE; PAIN; QUALITY OF LIFE;

EID: 84978042700     PISSN: 19739087     EISSN: 19739095     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Felson DT Development in the clinical understanding of osteoarthritis. Arthritis Research and Therapy 2009; 11:203-9.
2. Kidd BL Osteoarthritis and knee pain. Pain 2006; 123:6-9.
3. Berenbaum F. Osteoarthritis as an inflammatory disease (Osteoarthritis is not Osteoarthrosis!). Osteoarthritis and Cart 2013; 21:16-21.
4. Meredith D, Gehl KA. Characterization of sulphate transporters in isolated bovine articular condrocytes. J Orthop Res 2007; 25:1145-53.
5. Sanchez JC, Powell T. Electrophysiological demonstration of voltage-activated H+ in bovine articular condrocytes. Cell Physiol Biochem 2006; 18:85-90.
6. Bengtsson T, Aszodi A. Loss of integrins expression leads to moderate dysfunction of growth plate condrocytes. J Cell Sci 2005; 118:929-36.
7. Tetlow LC, Daman JA. Matrix metalloproteinases and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage. Arthritis Rheum 2001; 44:585-94.
8. Porter S, Clark IM. The ADAMTS metalloproteinases. Biochem J 2005; 386:15-27.
9. Pelletier JP, Mineau F. Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. Arthritis Rheum 1990; 33:1466-76.
10. Dahl LB, Dahl IMS Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Reum Dis 1985; 44:817-22.
11. Smith MD, Triantafillou S, Parker A, Youssef PP. Synovial membrane inflammation and citokine production in patients with early osteoarthritis. J 12. Rheumatol 1997; 24:365-71.
12. Brandt K. Intra-articular injection of hyaluronan as treatment for knee osteoarthritis. Arthritis Rheumatism 2000; 43:1192-203.
13. Yoshida M, Sai S, Marumo K, Tanaka T, Itano N, Kimata K, et al. Expression analysis of three isoforms of hyaluronan synthase and hyaluronidase in the synovium of knees in osteoarthritis and rheumatoid arthritis by quantitative real-time reverse transcriptase polymerase chain reaction. Arthritis Res Ther 2004; 6:514-20.
14. Gomis A, Pawlak M, Balazs EA. Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptions afferents. Arthritis Rheum 2004; 50:314-26.
15. Gomis A, Miralles A. Nociceptive nerve activity in an experimental model of knee joint osteoarthritis of the Guinea pig: effects of intraarticular hyaluronan application. Pain 2007; 130:126-36.
16. Ingram KR, Wann AK. Cyclic movement stimulates hyaluronan secretion into the synovial cavity of rabbit joints. J Physiol 2008; 586:1515-29.
17. Wann AKT, Ingram KR, Coleman PJ, McHale M. Mechanosensitive hyaluronan secretion: stimulus-response curves and role of transcription-translation-translocation in rabbit joints. Exp Physiol 2009; 94:350-61.
18. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl 1993; 39:3-9.
19. Foti C, Cisari C, Carda S, Giordan N, Rocco A, Frizziero A, Delia Bella G. A prospective observational study of the clinical efficacy and safety of intra-articular sodium hyaluronate in synovial joints with osteoarthritis. Eur J Phys Rehabil Med 2011; 47:407-15.
20. Goldberg VM, Buckwalter JA. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthritis Cart 2005; 13:216-24.
21. Culty M, Miyake K. Hyaluronan receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol 1990; 111:2765-74.
22. Dunn S, Kolomitkin O. Hyaluronan binding receptors: possible involvement in osteoarthritis. Mod Rheumatol 2009; 19:151-5.
23. Lee JY, Spicer AR. Hyaluronan: a multifunctional, megaDalton, stealth molecule. Curr Opin Cell Biol 2000; 12:581-6.
24. Hirota W. Intra-articular injection of hyaluronic acid reduce total amount of leukotriene C4, 6-keto-prostaglandin Fla, prostaglandin F2a and IL-1 ß in synovial fluid of patients with internal derangement in disorders of the temporomandibular joint. British Journal of Oral and Maxillofacial Surgery 1998; 36:35-8.
25. Kaneko S, Satoh T. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of pathients with osteoarthritis. Cytokines Cell Mol Ther 2000; 6:71-9.
26. Yasuda T. Hyaluronan inhibits prostaglandin E2 production via CD44 in U937 human macrophages. Tohoku J Exp Med 2010; 220:229-35.
27. Goto M, Hanyu T. Intra-articular injection of hyaluronate (SI-6601D) improves joint pain and synovial fluid prostaglandin E2 levels in rheumatoid arthritis: a multicenter clinical trial. Clin Exp Rheumatol 2001; 19:377-83.
28. Yatabe T. Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes. Ann Rheum Dis 2009; 68:1051-8.
29. Takahashi K, Goomer RS. The effect of hyaluronan on metalloproteinase-3 (MMP-3), interleukin-1 ß (IL-Iß), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Osteoarthritis Cartilage 1999; 7:182-90.
30. Peyron JG, Balazs EA. Preliminary clinical assessment of Na hyaluronate injection of the human knee. Pathol Biol 1974; 22:731-6.
31. Ghosh P, Smith MM. The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronan in the extracellular environment. Reumathol Int 1987; 7:113-22.
32. Bagga H. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol 2006; 33:946-50.
33. Ghosh P, Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum 2002; 32:10-37.
34. Lisignoli G, Grassi F. Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan. Arthritis Rheum 2011; 44:1800-07.
35. Grishko V. Effects of hyaluronic acids on mithocondrial function and mithocondria-driven apoptosis following oxidative stress in human condrocytes. J Biol Chem 2009; 14:9132-9.
36. Gomis A, Miralles A. Intra-articular injections of hyaluronan solutions of different elastoviscosity reduce nociceptive nerve activity in a model of osteoarthritic knee joint of the Guinea pig. Osteoarthritis Cartilage 2008; 17:798-804.
37. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analysis: the PRISMA statement. Int J Sur 2010; 8:336-41.
38. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analysis of studies that evaluate health care interventions: explaination and elaboration. PLoS Med 2009; 6: e1000100.
39. Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, Bouter LM, et al. The Delphi list: a criteria list for quality assessment of randomized clinical trial for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998; 51:1235-41.
40. Chen WL, Hsu WC, Lin YJ, Hsieh LF. Comparison of intra-articular hyaluronic acid injections with transcutaneous electric nerve stimulation for the management of knee osteoarthritis: a randomized controlled trial. Arch Phys Med Rehabil 2013; 94:1482-9.
41. Kawasaki T, Kurosawa H, Ikeda H, Takazawa Y, Ishijima M, Kubota M, et al. Therapeutic home exercise versus intraarticular hyaluronate injection for osteoarthritis of the knee: 6-month prospective randomized open-labeled trial. J Orthop Sci 2009; 14:182-91.
42. Paker N, Tekdös D, Kesiktas N, Soy D. Comparison of the therapeutic efficacy of TENS versus intra-articular hyaluronic acid injection in patients with knee osteoarthritis: a prospective randomized study. Adv Ther 2006; 23:342-53.
43. Atamaz F, Kirazli Y, Akkoc Y. A comparison of two different intraarticular hyaluronan drugs and physical therapy in the management of kneeosteoarthritis. Rheumatol Int 2006; 26:873-8.
44. Huang MH, Yang RC, Lee CL, Chen TW, Wang MC. Preliminary results of integrated therapy for patients with knee osteoarthritis. Arthritis Rheum 2005; 53:812-20.
45. Karatosun V, Unver B, Gocen Z, Sen A, Gunal I. Intra-articular hyaluronic acid compared with progressive knee exercises in osteoarthritis of the knee: a prospective randomized trial with long-term followup. Rheumatol Int 2006; 26:277-84.
46. Bayramoglu M, Karatas M, Cetin N, Akman N, Sözay S, Dilek A. Comparison of two different viscosupplements in knee osteoarthritis - a pilot study. Clin Rheumatol 2003; 22:118-22.
47. Karatosun V, Unver B, Ozden A, Ozay Z, Gunal I. Intra-articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long-term follow-up. Clin Exp Rheumatol 2008; 26:288-94.
48. Stitik TP, Levy JA. Viscosupplementation (Bioviscosupplementation) for osteoarthritis. Am J Phys Med Rehabil 2006; 85: S32-S50.
49. Yatabe T, Mokizuki S, Takizawwa M, et al. Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes. Ann Rheum Dis 2009; 68:1051-8.
50. Goldberg VM, Buckwalter JA. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthritis Cartilage 2005; 13:216-24.
51. Frizziero A, Maffulli N, Masiero S, Frizziero L. Six-months pain relief and functional recovery after intra-articular injections with hyaluronic acid (mw 500-730 kda) in trapeziometacarpal osteoarthritis. Muscles Ligaments Tendons J 2014; 4:256-61.
52. Jørgensen A, Stengaard-Pedersen K, Simonsen O, Pfeiffer-Jensen M, Eriksen C, Bliddal H, et al. Intra-articular hyaluronan is without clinical effect in knee osteoarthritis: a multicentre, randomised, placebocontrolled, double-blind study of 337 patients followed for 1 year. Ann Rheum Dis 2010; 69:1097-102.
53. Chang KV, Hung CY, Aliwarga F, Wang TG, Han DS, Chen WS. Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology: a systematic review and metaanalysis. Arch Phys Med Rehab 2014; 95:562-75.
54. Campbell KA, Erickson BJ, Saltzman BM, Mascarenhas R, Bach BR Jr, Cole BJ, et al. Is local viscosupplementation injection clinically superior to other therapies in the treatment of osteoarthritis of the knee: a systematic review of overlapping meta-analyses. Arthroscopy 2015; 31:2036-45.
55. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006; (2): CD005321.
56. Wang CT, Lin J, Chang CJ, Lin YT, Hou SM. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J bone Joint Surg Am 2004; 86-A: 538-45.
57. Osiri M, Welch V, Brosseau L, Shea B, McGowan J, Tugwell P, et al. Transcutaneous electrical nerve stimulation for knee osteoarthritis. Cochrane Database Syst Rev 2000; (4): CD002823.
58. McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage 2014; 22:363-88.
59. Alshami AM Knee osteoarthritis related pain: a narrative review of diagnosis and treatment. Int J Health Sci (Qassim) 2014; 8:85-104.
60. Rutjtes AW, Jüni P, da Costa BR, Trelle S, Nüesch E, Reichenbach S. Viscosupplementation for Osteoarthritis of the Knee. Ann Intern Med 2012; 157:180-91.
61. Waddell DD Viscosupplementation with hyaluronans for osteoarthritis of the knee: clinical efficacy and economic implications. Drugs Aging 2007; 24:629-42.
62. Hammesfahr JF, Knopf AB, Stitik T. Safety of intra-articular hyaluronates for pain associated with osteoarthritis of the knee. Am J Orthop (Belle Mead NJ) 2003; 32:277-83.
63. Lawrence RC, Felson DT, Heimick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008; 58:26-35.